Glaxo Smith Kline

Last Updated:
  • 38.23 EGP
  • 1.49
  • 4.06%
جلاكسو سميثكلاين
جلاكسو سميثكلاين
Symbol : BIOC
ISIN : EGS38171C012
Day Range : -
Turnover Ratio : 0.22
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Latest Announcements
2025-03-09 07:29:00.0اسم الشركة : جلاكسو سميثكلاينكود الترقيم الدولي : EGS38171C012كود رويترز : BIOC.CAالقوائم المالية المجمعة عن الفترة :من 01/01/202
2025-03-09 07:23:00.0اسم الشركة : جلاكسو سميثكلاينكود الترقيم الدولي : EGS38171C012كود رويترز : BIOC.CAالقوائم المالية غير المجمعة عن الفترة :من 01/01
2025-03-09 07:20:00.0Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions
2025-01-15 13:17:03.0Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure
2024-11-14 12:01:00.0Glaxo Smith Kline (BIOC.CA) Reports 9 Months Standalone Results

Glaxo Smith Kline Stock Overview

View Company Profile

Stock Summary

Last Price (EGP) 38.23
Prev. Close 36.740
Day Range 36.50 - 39.88
52WK range
Turnover (M EGP) 6.05
Volume (M) 0.16
Number of Trades 359
Market Cap (M EGP) 3,088.36
Change in Market Cap (M EGP)
VWAP (EGP) 38.29
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M EGP)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million...

Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1)...

Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024,...

Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse...

Cairo – Mubasher: GlaxoSmithKline’s (GSK Egypt) consolidated net profit plunged to EGP 60.47 million in 2023 from EGP 735.39 million a...